Dystonia is a syndrome of intermittent or sustained involuntary muscle contractions that frequently causes twisting and repetitive movements producing abnormal postures. These involuntary movements can affect many parts of the body (generalized) or affect more limited areas such as the focal dystonias. The pathophysiology of these syndromes remains unclear but a variety of clues suggest abnormalities of central dopaminergic pathways. We now have evidence that there is an abnormality of [18F]spiperone ([18F]SP) binding in the putamen, one of the key basal ganglia nuclei involved in motor control. [18F]SP, however, binds to both D2-like dopaminergic receptors and to S2 receptors in primate striatum. The objective of this research proposal is to determine whether patients with idiopathic focal dystonias have alterations in putaminal D2 dopaminergic receptors. Specifically, we hypothesize that patients with idiopathic focal dystonia have abnormal binding of putaminal D2-specific receptors and that receptor binding is somatotopically organized depending upon the body part involved. Additionally, we hypothesize that a genetic abnormality coding for a dopamine receptor may permit the development of these clinical manifestations. To test these hypotheses, we will measure dopamine receptor binding in vivo in patients with dystonias affecting their face (cranial dystonia) and the hand (hand cramp) as well as normals using positron emission tomography and a new dopamine D2 receptor radioligand, [18F]NMB. We will use magnetic resonance imaging to assist with precise localization of radioactive uptake in the putamen. We also will use a powerful new approach to analysis of genetic information called cladistics-based evolutionary analysis of the haplotypes of the DRD2 locus to try to identify the genetic abnormality that may predispose one to develop dystonia. These studies in addition to providing new insight into the pathophysiology of idiopathic dystonia also will help to understand and eventually treat conditions such as drug-induced involuntary movements produced by anti-psychotics as well as provide a better understanding of the function of the basal ganglia in the control of normal and abnormal movements.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS031001-06
Application #
2883658
Study Section
Diagnostic Radiology Study Section (RNM)
Program Officer
Sheehy, Paul A
Project Start
1992-09-24
Project End
2001-02-28
Budget Start
1999-03-01
Budget End
2001-02-28
Support Year
6
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Washington University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Black, Kevin J; Snyder, Abraham Z; Mink, Jonathan W et al. (2014) Spatial reorganization of putaminal dopamine D2-like receptors in cranial and hand dystonia. PLoS One 9:e88121
Eisenstein, Sarah A; Koller, Jon M; Piccirillo, Marilyn et al. (2012) Characterization of extrastriatal D2 in vivo specific binding of [ยน?F](N-methyl)benperidol using PET. Synapse 66:770-80
Karimi, Morvarid; Moerlein, Stephen M; Videen, Tom O et al. (2011) Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect? Mov Disord 26:100-6
Antenor-Dorsey, Jo Ann V; Laforest, Richard; Moerlein, Stephen M et al. (2008) Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates. Eur J Nucl Med Mol Imaging 35:771-8
Antenor-Dorsey, Jo Ann V; Markham, Joanne; Moerlein, Stephen M et al. (2008) Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans. Nucl Med Biol 35:335-41
Moerlein, S M; Perlmutter, J S; Markham, J et al. (1997) In vivo kinetics of [18F](N-methyl)benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding. J Cereb Blood Flow Metab 17:833-45
Moerlein, S M; Perlmutter, J S; Cutler, P D et al. (1997) Radiation dosimetry of [18F] (N-methyl)benperidol as determined by whole-body PET imaging of primates. Nucl Med Biol 24:311-8
Moerlein, S M; Perlmutter, J S; Welch, M J (1995) Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand. Nucl Med Biol 22:809-15